First real world analysis of safety in 0.19 mg fluocinolone acetonide (FAc, ILUVIEN) implant treated eyes receiving supplemental ocular steroid injection for diabetic macular edema (DME)
Year: 2019
Type: article
Author: Víctor H. González
Institution: Valley Retina Institute
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,850
OpenAlex ID: W3120061329
